Sensex
83,325.87 profit arw -107.02 (-0.13%)
Nifty
25,432.05 profit arw -28.95 (-0.11%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 30-Jun-2025
Corporate News
30-Jun-2025     09:29

Lyfius Pharma re-starts production at its Penicillin-G manufacturing facility

Aurobindo Pharma announced that its wholly owned step-down subsidiary, Lyfius Pharma has restarted the production at its Penicillin-G manufacturing facility, at Kakinada, Andhra Pradesh with immediate effect, after receiving the consent to operate from Andhra Pradesh Pollution Control Board on 29 June 2025.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

83,325.87 -107.02 (-0.13%)

Nifty

25,432.05 -28.95 (-0.11%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

23,916.07 -153.88(-0.64%)